Sunday, 9 June 2013

Zeffix

Zeffix

Generic name/Active ingredient: Lamivudine 100 mg
Trade name: Zeffix
Dosage form: Tablet
Drug classification: Nucleoside and nucleotide reverse transcriptase inhibitors antivirals
Legal classification: POM
Company: GlaxoSmithKline
Commonly used for: Treatment of patients ≥16 yr w/ chronic hepatitis B & evidence of HBV replication w/ ≥1 of the following conditions: Elevated serum ALT ≥2x normal, liver cirrhosis, decompensated liver disease, biopsy-proven necro-inflammatory liver disease, immunocompromised state, liver transplant.